Table 1.
Summary of personal and clinical factors of the study participants (N=204).
| Characteristics | Participants | |
| Age (y), mean (SD) | 65.2 (11.0) | |
| Sex, n (%) | ||
|
|
Male | 96 (47.1) |
|
|
Female | 108 (52.9) |
| Race, n (%) | ||
|
|
Racial and ethnic minority individualsa | 25 (12.3) |
|
|
Whitea | 179 (87.7) |
| Marital status, n (%) | ||
|
|
Currently married or living as married | 153 (75) |
|
|
Currently unmarried | 51 (25) |
| Educational background, n (%) | ||
|
|
College graduate or postgraduate | 108 (52.9) |
|
|
Grade school, high school, or some college | 96 (47.1) |
| Occupation, n (%) | ||
|
|
Unemployed, retired, disabled, or others | 150 (73.5) |
|
|
Full-time or part-time employee | 54 (26.5) |
| Cancer type, n (%) | ||
|
|
Colorectal cancer | 50 (24.5) |
|
|
Prostate cancer | 52 (25.5) |
|
|
Lung cancer | 50 (24.5) |
|
|
Breast cancer | 52 (25.5) |
| Taking OAAsb currently or previously, n (%) | ||
|
|
Yes | 140 (68.6) |
|
|
No | 64 (31.4) |
| Taking other outpatient medications currently, n (%) | ||
|
|
Yes | 146 (71.6) |
|
|
No | 58 (28.4) |
aRacial and ethnic minority individuals include Black or African American, Asian, or those who identified with >1 race.
bOAA: oral anticancer agent.